|
|
 |
|
Viewing report
|
|
|
|
European E-Clinical Trials Markets
Frost & Sullivan, April 2008, Pages: 70
This Frost & Sullivan research service titled European E-Clinical Trials Markets provides an overview of market dynamics and key programmes in the market, along with a complete analysis of key market drivers, restraints and trends in the e-clinical technologies markets in Europe. In this research, Frost & Sullivan's expert analyst thoroughly examines the market for Germany, France, the United Kingdom, Italy, Spain, Scandinavia and Benelux.
Market Overview
Cost and Clinical Benefits to Underline Appeal of E-clinical Trials
The pharmaceutical industry and contract research organisations (CROs) have steadily been moving towards greater automation and synergy. This has opened exciting growth potential for e-clinical technologies vendors. The fast-evolving clinical trial industry, in conjunction with information technology providers, has created different levels of opportunities, which, in turn, have influenced the type of clinical trial solutions being offered.
Pressures to increase drug research productivity and the need for enhanced data quality and cost reduction are fuelling the demand for e-clinical solutions. E-clinical technology is addressing the urgent need of bringing about greater efficiency in the drug discovery process and generating significant improvements in productivity. Such benefits are spurring the acceptance of e-clinical technologies. At the same time, e-clinical technologies are enabling life sciences companies to efficiently filter drug candidates by analysing data in real time. This is helping reduce the time required for validation checks, translating to considerable savings and higher revenues through the early introduction of drugs to the market. 'Tremendous scope and opportunity exists for e-clinical technology vendors to provide trial solutions and services that support the life sciences industry in being more cost effective and productive,' notes Frost & Sullivan Research Analyst E.Sujith. 'E-clinical trial solution vendors who can provide a one-shop stop for various types of clinical trial activities are poised to make particularly strong gains.'
Changing Regulations and Concerns about ROI to Hamper Adoption of E-clinical Technology
Constantly changing regulations present a serious challenge to sustained market expansion. In addition, there is a pressing need to achieve improved ROI in the coming years. 'E-clinical trial solutions offer a promising route to systematically overhaul the functioning of pharmaceutical companies and CROs,' remarks the analyst. 'However, the level of integration and investment required to realise this goal is high and remains a difficult proposition, and there is a need to convince customers about the ROI of e-clinical technologies, which presents a major challenge in the climate of industry-wide cost cutting.'
E-clinical technology vendors should help the clinical trial and pharmaceutical industries in addressing major areas of concern by establishing efficient IT infrastructure, automating paper-based processes and making the systems compliant with regulatory norms. Problems of integration, cost-cutting and intensifying competition in the pharmaceutical industry have prompted the need for innovative e-clinical technologies. With the regulatory authorities tightening the pressure on pharmaceutical companies and CROs, the need for better technology-driven workflows, processes and services has assumed more significance. This has created tremendous opportunities for firms that can provide scalable and cost-effective e-clinical trial solutions.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Bioinformatics
- Drug discovery
- Contract research
- IT infrastructure
Technologies
The following technology is covered in this research:
- Grid computing
Customers who bought this item also bought
U.S. Clinical Trial Management Systems Markets
European Clinical Diagnostics Automation Markets
Industry Insight Clinical Trials in India
Clinical Trials in India
Trends in Clinical Trials: Strategies to enhance clinical trial design
Spinal Surgery Clinical Trial Analysis
Innovations and Trends in Clinical Trials - Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology
Emerging Clinical Trial Locations: Market Dynamics and the Changing Healthcare and Regulatory Environment
Ultrasound Systems Clinical Trial Analysis
Inhalers Clinical Trial Analysis
Orthobiologics Clinical Trial Analysis
Opportunities for the European Mass Spectrometry Market in Clinical Applications
|
|
|
|
